维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Schaefer NG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	New derivatives of vitamin B12 show preferential targeting of tumors 显示文摘	WAIBEL R TREICHLER H SCHAEFER NG	2008	Cancer Res2008，68，8：	1
2	Non-Hodgkin lymphoma and Hodgkin disease:coregistered FDG PET and CT at staging and restaging do we need contrast-enhanced CT?显示文摘	Schaefer NG Hany TF Taverna C	2004	Radiology2004，232，3：	1
3	Non-Hodgkin lymphoma and Hodgkin disease:coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT显示文摘	Schaefer NG Hany TF Taverna C		0，，：	1
4	Non - Hodgkin lymphoma and Hodgkin disease: FDG -PET and CT at staging and restaging显示文摘	Schaefer NG	2004	Radiology2004，232，4：	1
5	New derivatives of vitamin B12 show preferential targeting of tumors 显示文摘	Waibel R Treichler H Schaefer NG	2008	Cancer Res2008，68，8：	1
6	Non-Hodgkin lymphoma and Hodgkin disease:coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT?显示文摘	Schaefer NG Hany TF Taverna C	2004	Radiology2004，232，3：	1
7	Non-Hodgkin lymphoma and Hodgkin disease:coregistered FDG PET and CT at staging and restaging:do we need contrast-enhanced CT? 显示文摘	Schaefer NG Hany TF Taverna C	2004	Radiology2004，232，：	1
8	Pulmonary hypertrophic osteoarthropathy in a potient with nonsmall cell lung cancer: diagnosis with FDG PET/CT显示文摘	Strbel K Schaefer NG Husarik DB	2006	Clin Nucl Med2006，31，：	1
9	Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast- enhanced CT? 显示文摘	Schaefer NG Hany TF Taverna C	2004	Radiology2004，232，3：	1
10	Non-Hodgkin lymphoma and Hodgkin disease; coregistered FDG PET and CT at staging and restaging do we need contrast-enhanced CT显示文摘	Schaefer NG Hany TF Taverna C		0，，：	1
11	New derivatives of vitamin B12 show preferential targeting of tumors 显示文摘	WAIBEL R TREICHLER H SCHAEFER NG	2008	Cancer Res2008，68，8：	1
12	Lipids and apolipoproteins in growth hormone - deficient children during treatment 显示文摘	Schaefer GB Greger NG Fesmire JD	1994	Metabo- lism1994，43，12：	1
13	Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma 显示文摘	Schaefer NG Geschwind JF Engles J	2012	Transl Res2012，159，1：	1
14	Non-Hedgkin lympho- ma and Hodgkin disease : coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT? 显示文摘	Schaefer NG Hang TF Taverna C	2004	Radiolgy2004，232，3：	1
15	Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma显示文摘	Collins Cl Ordonez NG Schaefer R	1992	Am J Pathol1992，141，4：	1
16	Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer:diagnosis with FDG PET/CT显示文摘	Strobel K Schaefer NG Husarik DB	2006	Clin Nucl Med2006，31，10：	1
17	Systemic administra- tion of 3 - bromopyruvate in treating disseminated aggressive lym- phoma 显示文摘	Schaefer NG Geschwind JF Engles J	2012	Trans Res2012，159，1：	1
18	Pulmonary hypertrophic osteo-arthropathy in a patient with nonsmall cell lung cancer:diagnosis with FDG PET/CT显示文摘	Strobel K Schaefer NG Husarik DB	2006	Clin Nucl Med2006，31，10：	1
19	Non-Hodgkin lymphoma andHodgkin disease:Coregistered FDG-PET and CT at staging andrestaging-Do we need contrast-enhanceed CT显示文摘	Schaefer NG Hang TF Traverna C	2004	Radiology2004，232，3：	1
20	Bone involvement in patients with lymphmna: the role of :SF-FDG PET/CT显示文摘	Schaefer NG Strobel K Taveerna C	2007	Eur J Nucl Med Mol Imaging2007，34，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示